COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report

Intern Emerg Med. 2021 Nov;16(8):2309-2311. doi: 10.1007/s11739-021-02787-9. Epub 2021 Jun 12.

Authors

Luigi Francesco Iannone¹, Pierangelo Geppetti¹, Alberto Chiarugi¹, Francesco De Cesaris²

Affiliations

¹ Headache Center and Clinical Pharmacology, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.
² Headache Center and Clinical Pharmacology, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy. francesco.decesaris@unifi.it.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
COVID-19 / complications
COVID-19 / diagnosis
COVID-19 Drug Treatment*
Dose-Response Relationship, Drug
Female
Humans
Migraine Disorders / complications
Migraine Disorders / drug therapy*
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
fremanezumab